Golden has been acquired by ComplyAdvantage.Read about it here ⟶

VerImmune

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

Overview Structured Data Issues Contributors Activity

verimmune.com

Is a

Company

Organization

Company attributes

Industry

Location

B2X

CEO

Pitchbook URL

pitchbook.com/profiles...466441-48

Number of Employees (Ranges)

1 – 10

Email Address

info@verimmune.com

Phone Number

+14434498836

Full Address

1812 ASHLAND AVENUE SUITE 100 BALTIMORE, MD 21205

CIK Number

Investors

Founded Date

2020

Total Funding Amount (USD)

7,000,000

Latest Funding Round Date

September 23, 2024

Latest Funding Type

Seed

Patents Assigned (Count)

Other attributes

Latest Funding Round Amount (USD)

4,500,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like VerImmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API